|
Young Empowered Scientists for ContinUed Research Engagement (YES for CURE)
|
5R25CA221738-02
|
$409,851
|
|
DECAPRIO, JAMES
|
DANA-FARBER CANCER INST
|
|
Yes 2 Success
|
1R25CA233431-01
|
$485,999
|
|
KITTLES, RICK
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Xeroderma Pigmentosum
|
ZIA CP010187 10777
|
$31,377
|
|
Achatz, Maria Isabel
|
DCEG (NCI)
|
|
Womens Interagency HIV Study (WIHS-V)
|
3U01AI035004-25S1
|
$144,370
|
|
ANASTOS, KATHRYN
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
WIHS Data Management and Analysis Center (WDMAC)
|
3U01AI042590-20S1
|
$95,311
|
|
GANGE, STEPHEN
|
JOHNS HOPKINS UNIVERSITY
|
|
WHI Hormones and Gynecologic Cancers Study
|
ZIA CP010126 10538
|
$43,086
|
|
Trabert, Britton
|
DCEG (NCI)
|
|
WEE1 inhibition and tumor immunity
|
1R01CA222963-01A1
|
$446,500
|
|
ZHANG, BIN
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
Washington Womens Interagency HIV/AIDS Study
|
3U01AI034994-24S1
|
$106,140
|
|
KASSAYE, SEBLE
|
GEORGETOWN UNIVERSITY
|
|
Vitamin D Pooling Project
|
ZIA CP010195 10436
|
$47,159
|
|
Albanes, Demetrius
|
DCEG (NCI)
|
|
Vitamin D Deficiency Leads to Increased Intra-Prostatic Androgens in African American Men
|
1R21CA231610-01
|
$208,670
|
|
NONN, LARISA
|
UNIVERSITY OF ILLINOIS AT CHICAGO
|
|
Vitamin D and HA Signaling in TNBC
|
3R01CA194500-04S1
|
$51,381
|
|
WELSH, JOELLEN
|
STATE UNIVERSITY OF NEW YORK AT ALBANY
|
|
Vitamin D and HA Signaling in TNBC
|
3R01CA194500-04S2
|
$57,310
|
|
WELSH, JOELLEN
|
STATE UNIVERSITY OF NEW YORK AT ALBANY
|
|
VIMORTP (Vanderbilt Integrated Molecular Oncology Research Training Program)
|
1T32CA217834-01A1
|
$241,750
|
|
RATHMELL, W
|
VANDERBILT UNIVERSITY MEDICAL CENTER
|
|
Validation of Siglec-6 as a novel target for cancer immunotherapy
|
1R21CA229961-01
|
$246,464
|
|
RADER, CHRISTOPH
|
SCRIPPS FLORIDA
|
|
Validation of a rapid point-of-care breath test for breast cancer
|
3R44CA203019-02S1
|
$224,700
|
|
PHILLIPS, MICHAEL
|
MENSSANA RESEARCH, INC.
|
|
Validation and Advanced Development of Albumin Oxidizability as a Marker of Plasma/Serum Integrity
|
1R33CA217702-01A1
|
$364,966
|
|
BORGES, CHAD
|
ARIZONA STATE UNIVERSITY-TEMPE CAMPUS
|
|
Validating and targeting USP35 for anticancer drug development
|
1U01CA222958-01A1
|
$349,766
|
|
LIU, CHANGWEI
|
UNIVERSITY OF COLORADO DENVER
|
|
USRT emerging technologies
|
ZIA CP010133 10748
|
$52,059
|
|
Kitahara, Cari
|
DCEG (NCI)
|
|
Using Microfluidic Single Cell Culture to Characterize Cancer Cell Asymmetric Division
|
7R01CA203810-02
|
$412,307
|
|
BUCKANOVICH, RONALD
|
MAGEE-WOMEN'S RES INST AND FOUNDATION
|
|
Unraveling the Complexities of Risk and Mechanism in Cancer
|
1R35CA220523-01A1
|
$978,294
|
|
QUACKENBUSH, JOHN
|
HARVARD SCHOOL OF PUBLIC HEALTH
|
|
Unmasking targetable dependencies in cancer with intrinsic or acquired resistance to anti-cancer therapies
|
5F99CA222728-02
|
$35,610
|
|
ANDERSON, GRACE
|
DUKE UNIVERSITY
|
|
University of Rochester Center for AIDS Research
|
3P30AI078498-10S1
|
$98,999
|
|
DEWHURST, STEPHEN
|
UNIVERSITY OF ROCHESTER
|
|
University of North Carolina Womens Interagency HIV Study UNC WIHS
|
3U01AI103390-05S1
|
$60,652
|
|
ADIMORA, ADAORA
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
University of California Global Health Institute Program for Fellows and Scholars
|
3D43TW009343-07S1
|
$123,840
|
|
COHEN, CRAIG
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Understanding tumor addiction to TRK fusions and sensitivity to TRK inhibition
|
1R01CA226864-01A1
|
$607,184
|
|
SCALTRITI, MAURIZIO
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
Uncovering Genotype Specific Vulnerabilities in KRAS Mutant Lung Cancer?
|
1R01CA227649-01A1
|
$387,731
|
|
PAPAGIANNAKOPOULOS, THALES
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
|
Uncertainty Methods Development
|
ZIA CP010185 10697
|
$65,633
|
|
Simon, Steven
|
DCEG (NCI)
|
|
UCLA Center for AIDS Research (CFAR)
|
3P30AI028697-28S1
|
$158,925
|
|
ZACK, JEROME
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
UAB-MISS WIHS Cohort
|
3U01AI103401-05S1
|
$64,985
|
|
KEMPF, MIRJAM-COLETTE
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
|
U01-Consortium for the Study of Chronic Pancreatitis, Diabetes and Pancreatic Cancer Clinical Centers
|
5U01DK108320-04
|
$190,000
|
|
FORSMARK, CHRISTOPHER
|
UNIVERSITY OF FLORIDA
|
|
Tumor-selective inhibition of DNA repair using pHLIP
|
1F30CA221065-01A1
|
$29,274
|
|
KAPLAN, ALANNA
|
YALE UNIVERSITY
|
|
Tumor-infiltrating T cell metabolic dysfunction and genetic reprogramming for effective immunotherapy
|
5F99CA222711-02
|
$44,524
|
|
SCHARPING, NICOLE
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
Tumor infiltrating lymphocyte therapy for human papillomavirus-positive cancers
|
ZIA BC 011478
|
$671,060
|
$13,421
|
Hinrichs, Christian
|
CCR (NCI)
|
|
Tumor cell-intrinsic STING signaling and IFN-Beta gene regulation in cancer
|
1F30CA232379-01
|
$49,524
|
|
FLOOD, BLAKE
|
UNIVERSITY OF CHICAGO
|
|
Trinity Field Study
|
ZIA CP010185 10694
|
$259,499
|
|
Simon, Steven
|
DCEG (NCI)
|
|
Triage of HPV-positive women
|
ZIA CP010124 10631
|
$960,814
|
|
Wentzensen, Nicolas
|
DCEG (NCI)
|
|
Treatment response and microRNA profiles in triple negative breast cancer patients receiving standard chemotherapy (TARMAC)
|
1K43TW010721-01A1
|
$74,124
|
|
NTEKIM, ATARA
|
UNIVERSITY OF IBADAN COLLEGE OF MEDICINE
|
|
Treatment of Acute Myeloid Leukemia with C2-Set Domain-Specific CD33 Antibodies
|
1R21CA223409-01A1
|
$191,400
|
|
WALTER, ROLAND
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Translational Regulation by RNA Regulating Proteins in Leukemia
|
1K99CA229993-01
|
$140,859
|
|
VU, LY
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
Translational Molecular and Cellular Imaging Technologies for Prostate Tumor Pathology
|
3R33CA196458-03S1
|
$66,508
|
|
BHARGAVA, ROHIT
|
UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN
|
|
Translational dysregulation of cell fate regulators drives oncogenic growth
|
1F30CA224951-01A1
|
$38,976
|
|
CAI, YI
|
UNIVERSITY OF WASHINGTON
|
|
Transient anti-BCMA CAR T-cells for Treatment of Multiple Myeloma
|
1R43CA221432-01A1
|
$299,042
|
|
STEWART, CHARLES
|
CARTESIAN THERAPEUTICS, INC.
|
|
Transcriptome profiling of highly degraded specimens through global analysis of short RNA fragments.
|
3R21CA217751-01S1
|
$50,000
|
|
NECHAEV, SERGEI
|
UNIVERSITY OF NORTH DAKOTA
|
|
Transcriptome profiling of highly degraded specimens through global analysis of short RNA fragments.
|
5R21CA217751-02
|
$173,750
|
|
NECHAEV, SERGEI
|
UNIVERSITY OF NORTH DAKOTA
|
|
Training program to promote diversity in cancer research
|
1R25CA229105-01
|
$125,517
|
|
WATABE, KOUNOSUKE
|
WAKE FOREST UNIVERSITY HEALTH SCIENCES
|
|
Training Program in Oncogenic Signals and Chromosome Biology
|
5T32CA108459-13
|
$262,884
|
|
HEYER, WOLF-DIETRICH
|
UNIVERSITY OF CALIFORNIA AT DAVIS
|
|
Training in Oncology Population Sciences (TOPS)
|
2T32CA092203-16
|
$451,220
|
|
SCHRAG, DEBORAH
|
DANA-FARBER CANCER INST
|
|
Training African Pathologists in Cancer Diagnosis
|
1R13CA232439-01
|
$38,120
|
|
WILSON, MICHAEL
|
AFRICAN STRATEGIES /ADVANCING PATHOLOGY
|
|
Towards commercialization of cavitation-enhancing nanodroplets for DNA sample fragmentation in NGS applications
|
1R43CA232902-01
|
$298,530
|
|
KASOJI, SANDEEP
|
TRIANGLE BIOTECHNOLOGY, INC.
|
|
Thyroid Tumor Sequencing study (Ukraine)
|
ZIA CP010132 10650
|
$101,333
|
|
Morton, Lindsay
|
DCEG (NCI)
|
Total relevant funding to Vaginal for this search: $1,552,758
|